MSB 2.91% $1.06 mesoblast limited

Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-7

  1. 8,320 Posts.
    lightbulb Created with Sketch. 805
    my heart raced... some good news! now how far off are we from the unblinding of the covid ards data?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.